Board Meeting Details

The Board meeting commenced at 4:00 PM and concluded at 6:30 PM on November 2, 2026. The Audit Committee reviewed and recommended the results for adoption at its meeting held on the same date.

Financial Results Overview (Standalone)

Quarter Ended September 30, 2026:

  • Total Revenue: ₹2,079.90 lakh
  • Profit Before Tax: ₹80.15 lakh
  • Total Tax Expense: ₹23.61 lakh (Current tax: ₹25.14 lakh, Deferred tax credit: ₹1.53 lakh)
  • Net Profit: ₹56.54 lakh
  • EPS (Basic & Diluted): ₹0.07 (not annualized)

Half Year Ended September 30, 2026:

  • Total Revenue: ₹4,334.45 lakh
  • Profit Before Tax: ₹180.89 lakh
  • Total Tax Expense: ₹48.97 lakh (Current tax: ₹51.54 lakh, Deferred tax credit: ₹2.57 lakh)
  • Net Profit: ₹131.92 lakh
  • EPS (Basic & Diluted): ₹0.17 (not annualized)

Financial Results Overview (Consolidated)

Quarter Ended September 30, 2026:

  • Total Revenue: ₹2,079.90 lakh
  • Profit Before Tax: ₹80.10 lakh
  • Total Tax Expense: ₹23.61 lakh
  • Net Profit: ₹56.49 lakh
  • EPS (Basic & Diluted): ₹0.07

Half Year Ended September 30, 2026:

  • Total Revenue: ₹4,334.45 lakh
  • Profit Before Tax: ₹180.84 lakh
  • Total Tax Expense: ₹48.97 lakh
  • Net Profit: ₹131.87 lakh
  • EPS (Basic & Diluted): ₹0.17

Balance Sheet Position (Standalone as of September 30, 2026)

  • Total Assets: ₹7,460.87 lakh (vs. ₹7,225.35 lakh as of March 31, 2026)
  • Equity Share Capital: ₹3,793.64 lakh
  • Other Equity: ₹2,313.50 lakh
  • Total Equity: ₹6,107.14 lakh
  • Current Liabilities: ₹1,276.85 lakh
  • Non-current Liabilities: ₹76.89 lakh

Rights Issue Proceeds Utilization

As of September 30, 2026:

  • Total Issue Size: ₹3,458.15 lakh
  • Funds Utilized: ₹2,688.15 lakh
  • Funds Unutilized: ₹770.00 lakh (held in fixed deposits)

Breakdown of Utilization:

  • Working Capital Requirements: ₹1,787.00 lakh (fully utilized)
  • General Corporate Purpose: ₹901.15 lakh (fully utilized)
  • Loan Repayment to State Bank of India: ₹0.00 utilized of ₹770.00 lakh allocated

Note: The object for ₹770.00 lakh was modified from "Capital Expenditure" to "Repayment of Outstanding Loan from SBI" with shareholder approval filed via Form MGT-14 dated August 3, 2026.

Subsidiary Information

Consolidated results include Narmada Bio Feed Private Limited (wholly-owned subsidiary) with total assets of ₹0.15 lakh as of September 30, 2026, and total comprehensive loss of ₹0.01 lakh for H1 FY27.

Auditor Review

Jain Kedia & Sharma, Chartered Accountants (FRN: 103920W), issued unmodified limited review reports on both standalone and consolidated financial results. Partner Ashish Sharma (Membership No. 142788) signed the reports dated November 2, 2026.

Additional Corporate Action

The company approved sub-division of equity shares from face value of ₹10 to ₹5 per share, increasing share count from 37,93,639 to 75,87,279 shares, without change in total paid-up capital. This was approved at the AGM held on July 18, 2026.

Financial Statement Availability

The results are available on company website (www.narmadaagrobase.com) and stock exchange websites (BSE and NSE).